Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
about
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsModeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit developmentIn vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophreniaUsing NMR approaches to drive the search for new CNS therapeutics.Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review.New N-aryl-N'-(3-(substituted)phenyl)-N'-methylguanidines as leads to potential PET radioligands for imaging the open NMDA receptor.Corticotropin releasing hormone and imaging, rethinking the stress axis.Translating glutamate: from pathophysiology to treatment.Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.Species-conserved reconfigurations of brain network topology induced by ketamineFluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease.In vivo measurements of glutamate, GABA, and NAAG in schizophreniaN'-3-(Trifluoromethyl)phenyl Derivatives of N-Aryl-N'-methylguanidines as Prospective PET Radioligands for the Open Channel of the N-Methyl-d-aspartate (NMDA) Receptor: Synthesis and Structure-Affinity RelationshipsNeurochemical and Neuroanatomical Plasticity Following Memory Training and Yoga Interventions in Older Adults with Mild Cognitive Impairment.Serotonin 2A receptor antagonists for treatment of schizophrenia.Drug targets: single-cell transcriptomics hastens unbiased discoveryThe psychosis high-risk state: a comprehensive state-of-the-art review.Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors.Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia.PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) Inhibitor.Increase in glutamate/glutamine concentration in the medial prefrontal cortex during mental imagery: A combined functional mrs and fMRI study.Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics.
P2860
Q26744729-53FEFD65-2416-4D68-A444-465C64462DE3Q28081179-C343BD58-7D9F-4B80-81A4-01DD05491E86Q28083121-CE1DE795-3E98-4678-85CF-473CF66B3F3DQ33613767-181ADBE9-6CE1-4BCC-93D2-80DE37565CA2Q34034400-D7B3EE54-0B4F-445E-B944-383CD18418ADQ34949467-484EFBA8-A506-46C5-9D46-40E885E35358Q35181618-6B71B4A8-53CF-4553-8BF5-454D986D93AAQ35739457-ACFA023D-3305-4169-92F4-D2B6AFD0500BQ36579965-324F7223-B6FB-45B5-A092-712958BBAE03Q36915397-F0517C1F-93A0-4971-8728-C50FE11324A5Q37086598-1F8B23FB-16B5-4B74-B1E9-EE56EE07412DQ37131013-C9689A8A-0186-4432-90D8-9B74771FBDF1Q37166728-6FC828E8-443A-4A27-A020-CC58B2B0B8E0Q37424431-E58A16E6-E6D2-4EE3-A069-E05B9A4B4E77Q37899193-7360E0FA-AAFB-41AA-B52F-110231D2167EQ37950158-68D71CE6-E493-4CD4-AF24-9E1A20A02D99Q38061036-D9BC9580-2FE2-44C5-9BC6-2190A95A4265Q38166973-86885917-CD2F-4B7C-9874-3F735A541056Q39629972-40F7CF50-04EC-45A1-A0D2-CE7EC2F31543Q42369736-87565783-1946-471F-B565-9B1C062DFA46Q42544021-766F93A1-6526-48BB-A770-886DC19C3D46Q46308311-3E2E49D3-D239-4DE6-970A-55808F190C7CQ48035285-14B3D04D-75CB-4AFE-A1CC-23E725FCE62EQ48277673-B198C164-D31E-4257-8244-05DD548D4826
P2860
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
@ast
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
@en
type
label
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
@ast
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
@en
prefLabel
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
@ast
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
@en
P1476
Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
@en
P304
P356
10.2174/138161209788957438
P50
P577
2009-01-01T00:00:00Z